ELITE PHARMACEUTICALS INC /NV/ reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,221 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 701-725 of 759 matching filings.

Per page
25
Current page
29
4

4 filing

Filing date
12 Apr 2011
Reporting date
11 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Apr 2011
Reporting date
06 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
07 Apr 2011
Reporting date
04 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K filing

Filing date
06 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
17 Mar 2011
Reporting date
11 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2011
Reporting date
03 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Mar 2011
Reporting date
03 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2011
Reporting date
03 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2011
Reporting date
03 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2011
Reporting date
03 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2011
Reporting date
18 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2011
Reporting date
18 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2011
Reporting date
03 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K filing

Filing date
04 Mar 2011
Reporting date
02 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Feb 2011
Reporting date
23 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
23 Feb 2011
Reporting date
23 Feb 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59693

SC 13G/A filing

Filing date
15 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-59693

SC 13G/A filing

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-59693

SCHEDULE 13G

Filing date
14 Feb 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-15697

10-Q

Filing date
14 Feb 2011
Reporting date
31 Dec 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
04 Feb 2011
Reporting date
31 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K filing

Filing date
13 Jan 2011
Reporting date
11 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Jan 2011
Reporting date
10 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K filing

Filing date
10 Jan 2011
Reporting date
04 Jan 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .